Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-07

AUTHORS

Yuko Shimamoto, Tsuyoshi Fukuda, Kazuhiko Tanaka, Katsuya Komori, Daikai Sadamitsu

ABSTRACT

PURPOSE: Vancomycin has been used in patients with sepsis infected by MRSA and shows large interindividual variability in its dosing. In this observational study the potential influence of sepsis status on the vancomycin dose requirement in relation to systemic inflammatory response syndrome (SIRS) criteria was assessed. METHODS: From about 250 patients receiving serum vancomycin monitoring from May 2006 to April 2011 at the Osaka National Hospital, 105 adult patients who had been assessed using the SIRS criteria were identified. Patients on chemotherapy or intermittent positive pressure ventilation in whom the SIRS criteria could not accurately evaluate inflammatory status were excluded. Using two vancomycin serum concentrations at peak and trough, individual pharmacokinetic parameters were calculated by the Bayesian estimation method using a two-compartment model. Creatinine clearance rate was estimated by the Cockcroft-Gault formula (eCcr). RESULTS: Patients with SIRS had a significantly higher vancomycin clearance than those without SIRS, indicating that SIRS patients had a higher elimination capacity. The vancomycin clearance was positively correlated with the SIRS score defined as the number of positive items in the criteria, and negatively with age, except in patients with renal dysfunction. A linear relationship between the vancomycin clearance and eCcr remained even in the supernormal eCcr phase (more than approximately 120 mL/min). CONCLUSIONS: This study provides a new insight into the need for quick prediction of dose requirement. That is, an increased vancomycin dosage would be needed in patients with a higher SIRS score to maintain the therapeutic target concentration, in particular in those with a high eCcr value. More... »

PAGES

1247-1252

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00134-013-2909-9

DOI

http://dx.doi.org/10.1007/s00134-013-2909-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041975219

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23604132


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bayes Theorem", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Linear Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Systemic Inflammatory Response Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vancomycin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National Cerebral and Cardiovascular Center", 
          "id": "https://www.grid.ac/institutes/grid.410796.d", 
          "name": [
            "Department of Pharmacy, National Hospital Organization Osaka National Hospital, Osaka, Japan", 
            "Department of Pharmacy, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, 565-8565, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimamoto", 
        "givenName": "Yuko", 
        "id": "sg:person.01263573766.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263573766.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cincinnati", 
          "id": "https://www.grid.ac/institutes/grid.24827.3b", 
          "name": [
            "Division of Clinical Pharmacology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH, USA", 
            "Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukuda", 
        "givenName": "Tsuyoshi", 
        "id": "sg:person.0747152577.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747152577.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osaka University of Pharmaceutical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.444888.c", 
          "name": [
            "Department of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanaka", 
        "givenName": "Kazuhiko", 
        "id": "sg:person.010167263554.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010167263554.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osaka National Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416803.8", 
          "name": [
            "Department of Pharmacy, National Hospital Organization Osaka National Hospital, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komori", 
        "givenName": "Katsuya", 
        "id": "sg:person.0645612766.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645612766.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osaka National Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416803.8", 
          "name": [
            "Department of Traumatology and Critical Care Medical Center, National Hospital Organization Osaka National Hospital, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sadamitsu", 
        "givenName": "Daikai", 
        "id": "sg:person.01200277661.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200277661.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1053/j.ajkd.2008.12.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/41.suppl_1.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003312498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.32.6.848", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007982826"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003246-199206000-00025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011749803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003246-199206000-00025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011749803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.25.4.433", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012472519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200443130-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015038530", 
          "https://doi.org/10.2165/00003088-200443130-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200443130-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015038530", 
          "https://doi.org/10.2165/00003088-200443130-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200443130-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015038530", 
          "https://doi.org/10.2165/00003088-200443130-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrneph.2011.92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017243553", 
          "https://doi.org/10.1038/nrneph.2011.92"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-198611040-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018467669", 
          "https://doi.org/10.2165/00003088-198611040-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.44.5.1247-1254.2000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018848901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198905043201806", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022479874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijantimicag.2011.12.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023772061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijantimicag.2012.05.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031474667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200645080-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035097491", 
          "https://doi.org/10.2165/00003088-200645080-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200645080-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035097491", 
          "https://doi.org/10.2165/00003088-200645080-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccc.2010.09.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035281772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11318140-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039277611", 
          "https://doi.org/10.2165/11318140-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11318140-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039277611", 
          "https://doi.org/10.2165/11318140-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000180580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051087304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ccm.0b013e3181961bff", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051162165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ccm.0b013e3181961bff", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051162165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/14.suppl_d.73", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059730670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007691-199804000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060274524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007691-199804000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060274524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007691-199804000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060274524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138920111798808446", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069177984"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-07", 
    "datePublishedReg": "2013-07-01", 
    "description": "PURPOSE: Vancomycin has been used in patients with sepsis infected by MRSA and shows large interindividual variability in its dosing. In this observational study the potential influence of sepsis status on the vancomycin dose requirement in relation to systemic inflammatory response syndrome (SIRS) criteria was assessed.\nMETHODS: From about 250 patients receiving serum vancomycin monitoring from May 2006 to April 2011 at the Osaka National Hospital, 105 adult patients who had been assessed using the SIRS criteria were identified. Patients on chemotherapy or intermittent positive pressure ventilation in whom the SIRS criteria could not accurately evaluate inflammatory status were excluded. Using two vancomycin serum concentrations at peak and trough, individual pharmacokinetic parameters were calculated by the Bayesian estimation method using a two-compartment model. Creatinine clearance rate was estimated by the Cockcroft-Gault formula (eCcr).\nRESULTS: Patients with SIRS had a significantly higher vancomycin clearance than those without SIRS, indicating that SIRS patients had a higher elimination capacity. The vancomycin clearance was positively correlated with the SIRS score defined as the number of positive items in the criteria, and negatively with age, except in patients with renal dysfunction. A linear relationship between the vancomycin clearance and eCcr remained even in the supernormal eCcr phase (more than approximately 120\u00a0mL/min).\nCONCLUSIONS: This study provides a new insight into the need for quick prediction of dose requirement. That is, an increased vancomycin dosage would be needed in patients with a higher SIRS score to maintain the therapeutic target concentration, in particular in those with a high eCcr value.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00134-013-2909-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313639", 
        "issn": [
          "0342-4642", 
          "1432-1238"
        ], 
        "name": "Intensive Care Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "name": "Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis", 
    "pagination": "1247-1252", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c7f348f140bbaddad5e60120c98367bc819bab696caf2f963f09d9eb9d194f32"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23604132"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7704851"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00134-013-2909-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041975219"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00134-013-2909-9", 
      "https://app.dimensions.ai/details/publication/pub.1041975219"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000482.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00134-013-2909-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00134-013-2909-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00134-013-2909-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00134-013-2909-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00134-013-2909-9'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      21 PREDICATES      63 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00134-013-2909-9 schema:about N00e351f58deb49579564cf16c90fc309
2 N1bebbe315e624ebc9c79f9a40a582d41
3 N269b9fa80460436d94e77b6676408c9f
4 N3fbb5d415b2a4cfca4b03e4436199f87
5 N43bc3e65272949139982991535adf75e
6 N5289fc2a944f4e82bd5df40c4179fb75
7 N5e1cb2d3440647359c4005ea4ee83514
8 N77639d5b1a8a4bc6b2837f32674d9821
9 N803b66ba1bec4e44bf988aa09a166c94
10 N87a5a06b69204ed0aa8b1ab6e0d34927
11 Naca76f88c4504e5da1dca0eed0f7a0a8
12 Nb62c67d7fd0f47b9a28d726fdeac5ef6
13 Nf4ae0919105b4041b38c2d581fdc12b8
14 Nfa160931f68e4c7695fe3ed133110570
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N150332e4ea7848ea982e2da8d28429ca
18 schema:citation sg:pub.10.1038/nrneph.2011.92
19 sg:pub.10.2165/00003088-198611040-00001
20 sg:pub.10.2165/00003088-200443130-00005
21 sg:pub.10.2165/00003088-200645080-00001
22 sg:pub.10.2165/11318140-000000000-00000
23 https://doi.org/10.1016/j.ccc.2010.09.006
24 https://doi.org/10.1016/j.ijantimicag.2011.12.011
25 https://doi.org/10.1016/j.ijantimicag.2012.05.010
26 https://doi.org/10.1053/j.ajkd.2008.12.034
27 https://doi.org/10.1056/nejm198905043201806
28 https://doi.org/10.1093/jac/14.suppl_d.73
29 https://doi.org/10.1093/jac/41.suppl_1.1
30 https://doi.org/10.1097/00003246-199206000-00025
31 https://doi.org/10.1097/00007691-199804000-00003
32 https://doi.org/10.1097/ccm.0b013e3181961bff
33 https://doi.org/10.1128/aac.25.4.433
34 https://doi.org/10.1128/aac.32.6.848
35 https://doi.org/10.1128/aac.44.5.1247-1254.2000
36 https://doi.org/10.1159/000180580
37 https://doi.org/10.2174/138920111798808446
38 schema:datePublished 2013-07
39 schema:datePublishedReg 2013-07-01
40 schema:description PURPOSE: Vancomycin has been used in patients with sepsis infected by MRSA and shows large interindividual variability in its dosing. In this observational study the potential influence of sepsis status on the vancomycin dose requirement in relation to systemic inflammatory response syndrome (SIRS) criteria was assessed. METHODS: From about 250 patients receiving serum vancomycin monitoring from May 2006 to April 2011 at the Osaka National Hospital, 105 adult patients who had been assessed using the SIRS criteria were identified. Patients on chemotherapy or intermittent positive pressure ventilation in whom the SIRS criteria could not accurately evaluate inflammatory status were excluded. Using two vancomycin serum concentrations at peak and trough, individual pharmacokinetic parameters were calculated by the Bayesian estimation method using a two-compartment model. Creatinine clearance rate was estimated by the Cockcroft-Gault formula (eCcr). RESULTS: Patients with SIRS had a significantly higher vancomycin clearance than those without SIRS, indicating that SIRS patients had a higher elimination capacity. The vancomycin clearance was positively correlated with the SIRS score defined as the number of positive items in the criteria, and negatively with age, except in patients with renal dysfunction. A linear relationship between the vancomycin clearance and eCcr remained even in the supernormal eCcr phase (more than approximately 120 mL/min). CONCLUSIONS: This study provides a new insight into the need for quick prediction of dose requirement. That is, an increased vancomycin dosage would be needed in patients with a higher SIRS score to maintain the therapeutic target concentration, in particular in those with a high eCcr value.
41 schema:genre research_article
42 schema:inLanguage en
43 schema:isAccessibleForFree false
44 schema:isPartOf N11cb2ef1f7d04bf09270e3d252b627c5
45 N9d1465518fef4bc8ae5c20902e52dd3a
46 sg:journal.1313639
47 schema:name Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis
48 schema:pagination 1247-1252
49 schema:productId N179f7487781c4628a576260d20096909
50 N911dcc59f5a54327918d5143c798d28a
51 Nace7b85734bb412d88474bdfa615f9fb
52 Nb10a829901b243c1af2d4f3be14b1eae
53 Ncd4a0a55e1304e06856fc630a392cb11
54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041975219
55 https://doi.org/10.1007/s00134-013-2909-9
56 schema:sdDatePublished 2019-04-10T21:30
57 schema:sdLicense https://scigraph.springernature.com/explorer/license/
58 schema:sdPublisher N3d35396cdcfa4f7fb3347b7e845e5bc4
59 schema:url http://link.springer.com/10.1007/s00134-013-2909-9
60 sgo:license sg:explorer/license/
61 sgo:sdDataset articles
62 rdf:type schema:ScholarlyArticle
63 N00e351f58deb49579564cf16c90fc309 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Linear Models
65 rdf:type schema:DefinedTerm
66 N11cb2ef1f7d04bf09270e3d252b627c5 schema:issueNumber 7
67 rdf:type schema:PublicationIssue
68 N150332e4ea7848ea982e2da8d28429ca rdf:first sg:person.01263573766.57
69 rdf:rest N953c3c98c2684c479b6ddea6d07fe553
70 N179f7487781c4628a576260d20096909 schema:name doi
71 schema:value 10.1007/s00134-013-2909-9
72 rdf:type schema:PropertyValue
73 N1bebbe315e624ebc9c79f9a40a582d41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Female
75 rdf:type schema:DefinedTerm
76 N269b9fa80460436d94e77b6676408c9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Dose-Response Relationship, Drug
78 rdf:type schema:DefinedTerm
79 N3d35396cdcfa4f7fb3347b7e845e5bc4 schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 N3fbb5d415b2a4cfca4b03e4436199f87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Humans
83 rdf:type schema:DefinedTerm
84 N43bc3e65272949139982991535adf75e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Multivariate Analysis
86 rdf:type schema:DefinedTerm
87 N5289fc2a944f4e82bd5df40c4179fb75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Bayes Theorem
89 rdf:type schema:DefinedTerm
90 N5e1cb2d3440647359c4005ea4ee83514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Vancomycin
92 rdf:type schema:DefinedTerm
93 N67a5191b7ba34ca2b60a0f03e74007eb rdf:first sg:person.010167263554.08
94 rdf:rest Nc8c64957d7d14e2fb42bf4f5219c2e91
95 N77639d5b1a8a4bc6b2837f32674d9821 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Male
97 rdf:type schema:DefinedTerm
98 N803b66ba1bec4e44bf988aa09a166c94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Systemic Inflammatory Response Syndrome
100 rdf:type schema:DefinedTerm
101 N87a5a06b69204ed0aa8b1ab6e0d34927 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Anti-Bacterial Agents
103 rdf:type schema:DefinedTerm
104 N911dcc59f5a54327918d5143c798d28a schema:name pubmed_id
105 schema:value 23604132
106 rdf:type schema:PropertyValue
107 N953c3c98c2684c479b6ddea6d07fe553 rdf:first sg:person.0747152577.52
108 rdf:rest N67a5191b7ba34ca2b60a0f03e74007eb
109 N9d1465518fef4bc8ae5c20902e52dd3a schema:volumeNumber 39
110 rdf:type schema:PublicationVolume
111 Naca76f88c4504e5da1dca0eed0f7a0a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Adult
113 rdf:type schema:DefinedTerm
114 Nace7b85734bb412d88474bdfa615f9fb schema:name readcube_id
115 schema:value c7f348f140bbaddad5e60120c98367bc819bab696caf2f963f09d9eb9d194f32
116 rdf:type schema:PropertyValue
117 Nb10a829901b243c1af2d4f3be14b1eae schema:name dimensions_id
118 schema:value pub.1041975219
119 rdf:type schema:PropertyValue
120 Nb62c67d7fd0f47b9a28d726fdeac5ef6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Age Factors
122 rdf:type schema:DefinedTerm
123 Nb9a59189db3e40f1b1347c2f65b712d5 rdf:first sg:person.01200277661.54
124 rdf:rest rdf:nil
125 Nc8c64957d7d14e2fb42bf4f5219c2e91 rdf:first sg:person.0645612766.31
126 rdf:rest Nb9a59189db3e40f1b1347c2f65b712d5
127 Ncd4a0a55e1304e06856fc630a392cb11 schema:name nlm_unique_id
128 schema:value 7704851
129 rdf:type schema:PropertyValue
130 Nf4ae0919105b4041b38c2d581fdc12b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Middle Aged
132 rdf:type schema:DefinedTerm
133 Nfa160931f68e4c7695fe3ed133110570 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Metabolic Clearance Rate
135 rdf:type schema:DefinedTerm
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
140 schema:name Clinical Sciences
141 rdf:type schema:DefinedTerm
142 sg:journal.1313639 schema:issn 0342-4642
143 1432-1238
144 schema:name Intensive Care Medicine
145 rdf:type schema:Periodical
146 sg:person.010167263554.08 schema:affiliation https://www.grid.ac/institutes/grid.444888.c
147 schema:familyName Tanaka
148 schema:givenName Kazuhiko
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010167263554.08
150 rdf:type schema:Person
151 sg:person.01200277661.54 schema:affiliation https://www.grid.ac/institutes/grid.416803.8
152 schema:familyName Sadamitsu
153 schema:givenName Daikai
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200277661.54
155 rdf:type schema:Person
156 sg:person.01263573766.57 schema:affiliation https://www.grid.ac/institutes/grid.410796.d
157 schema:familyName Shimamoto
158 schema:givenName Yuko
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263573766.57
160 rdf:type schema:Person
161 sg:person.0645612766.31 schema:affiliation https://www.grid.ac/institutes/grid.416803.8
162 schema:familyName Komori
163 schema:givenName Katsuya
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645612766.31
165 rdf:type schema:Person
166 sg:person.0747152577.52 schema:affiliation https://www.grid.ac/institutes/grid.24827.3b
167 schema:familyName Fukuda
168 schema:givenName Tsuyoshi
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747152577.52
170 rdf:type schema:Person
171 sg:pub.10.1038/nrneph.2011.92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017243553
172 https://doi.org/10.1038/nrneph.2011.92
173 rdf:type schema:CreativeWork
174 sg:pub.10.2165/00003088-198611040-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018467669
175 https://doi.org/10.2165/00003088-198611040-00001
176 rdf:type schema:CreativeWork
177 sg:pub.10.2165/00003088-200443130-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015038530
178 https://doi.org/10.2165/00003088-200443130-00005
179 rdf:type schema:CreativeWork
180 sg:pub.10.2165/00003088-200645080-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035097491
181 https://doi.org/10.2165/00003088-200645080-00001
182 rdf:type schema:CreativeWork
183 sg:pub.10.2165/11318140-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039277611
184 https://doi.org/10.2165/11318140-000000000-00000
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.ccc.2010.09.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035281772
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.ijantimicag.2011.12.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023772061
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.ijantimicag.2012.05.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031474667
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1053/j.ajkd.2008.12.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000437042
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1056/nejm198905043201806 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022479874
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1093/jac/14.suppl_d.73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059730670
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1093/jac/41.suppl_1.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003312498
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1097/00003246-199206000-00025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011749803
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1097/00007691-199804000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060274524
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1097/ccm.0b013e3181961bff schema:sameAs https://app.dimensions.ai/details/publication/pub.1051162165
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1128/aac.25.4.433 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012472519
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1128/aac.32.6.848 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007982826
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1128/aac.44.5.1247-1254.2000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018848901
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1159/000180580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051087304
213 rdf:type schema:CreativeWork
214 https://doi.org/10.2174/138920111798808446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069177984
215 rdf:type schema:CreativeWork
216 https://www.grid.ac/institutes/grid.24827.3b schema:alternateName University of Cincinnati
217 schema:name Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
218 Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
219 rdf:type schema:Organization
220 https://www.grid.ac/institutes/grid.410796.d schema:alternateName National Cerebral and Cardiovascular Center
221 schema:name Department of Pharmacy, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, 565-8565, Osaka, Japan
222 Department of Pharmacy, National Hospital Organization Osaka National Hospital, Osaka, Japan
223 rdf:type schema:Organization
224 https://www.grid.ac/institutes/grid.416803.8 schema:alternateName Osaka National Hospital
225 schema:name Department of Pharmacy, National Hospital Organization Osaka National Hospital, Osaka, Japan
226 Department of Traumatology and Critical Care Medical Center, National Hospital Organization Osaka National Hospital, Osaka, Japan
227 rdf:type schema:Organization
228 https://www.grid.ac/institutes/grid.444888.c schema:alternateName Osaka University of Pharmaceutical Sciences
229 schema:name Department of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sciences, Osaka, Japan
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...